SCHEMBL10330508

SCHEMBL10330508

COc1ccccc1C(=O)NC(C)CC(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.62
ALDH1A1 P00352 2/20 0.62
CTSD P07339 1/20 0.59
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
KDM4E B2RXH2 1/20 0.57
HSD17B10 Q99714 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.56
TDP1 Q9NUW8 1/20 0.54
STAT3 P40763 2/20 0.53
TP53 P04637 1/20 0.52
GLA P06280 1/20 0.52
LMNA P02545 1/20 0.52
KCNA3 P22001 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
PDE10A Q9Y233 1/20 0.51
KCNK3 O14649 2/20 0.50
KCNK9 Q9NPC2 2/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758147 0.85 HPGD (0.63) HPGDALDH1A1CTSDMEN1KMT2A
SCHEMBL4758150 0.85 HPGD (0.63) HPGDALDH1A1CTSDMEN1KMT2A
SCHEMBL18893131 0.84 L3MBTL1 (0.74) HPGDALDH1A1CTSDHSD17B10L3MBTL1
SCHEMBL12402268 0.84 HPGD (0.61) HPGDALDH1A1CTSDMEN1KMT2A
Alcohol SCHEMBL6836623 0.83 L3MBTL1 (0.68) HPGDALDH1A1CTSDMEN1KMT2A
SCHEMBL22251169 0.81 HPGD (0.58) HPGDALDH1A1CTSDMEN1KMT2A
SCHEMBL8029750 0.81 HPGD (0.69) HPGDALDH1A1CTSDHSD17B10L3MBTL1
SCHEMBL24568217 0.80 HPGD (0.68) HPGDALDH1A1CTSDHSD17B10L3MBTL1
SCHEMBL24801412 0.80 HPGD (0.68) HPGDALDH1A1CTSDHSD17B10L3MBTL1
SCHEMBL2251629 0.78 HPGD (0.70) HPGDALDH1A1CTSDKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564211-A1 DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND USES THEREOF LANDSTEINER GENMED, S.L. (ES) 2019-11-06 EP disclosed
US-20120184438-A1 FORMULATIONS SYNGENTA CROP PROTECTION, LLC (US) 2012-07-19 US disclosed
US-20120184438-A1 FORMULATIONS SYNGENTA CROP PROTECTION, LLC (US) 2012-07-19 US disclosed
WO-2011010082-A2 FORMULATIONS SYNGENTA LIMITED (GB) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184438-A1 FORMULATIONS CBR3, H1-5, H1-0 HPGD 3011/4885ALDH1A1 935/4885CTSD 2649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.